Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 4 7Phase NA 5Phase 3 2Phase 1/2 1Phase 1 1

Status

Completed 95Terminated 23Unknown 20Recruiting 10Active not recruiting 7Withdrawn 3Suspended 2Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 91Thoracic 54Breast 51Gynecologic 29Genitourinary 28Head & Neck 25Lymphoid 18Other hematologic neoplasm 16CNS 12Plasma cell 9Sarcoma 7Tumor-Agnostic 6Dermatologic 6Endocrine 4Myeloid 3Classical hematology 2Other solid neoplasm 1NET 1

Conditions

Venous Thromboembolism 1Multiple Myeloma 1Hematologic Neoplasms 1Febrile Neutropenia 1

Interventions

Rivaroxaban 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Not yet recruiting × Classical hematology × Clear all
NCT06580223 2025-07-18

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 3 Not yet recruiting
530 enrolled
Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT06278896 2024-02-26

END

Brigham and Women's Hospital

Phase 3 Not yet recruiting
260 enrolled
Classical hematologyOther hematologic neoplasm

Hematologic Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡